387 related articles for article (PubMed ID: 23262249)
1. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Mandorfer M; Heinisch BB; Hayden H; Lammert F; Trauner M; Peck-Radosavljevic M; Vogelsang H;
J Hepatol; 2013 May; 58(5):911-21. PubMed ID: 23262249
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
Montes-de-Oca M; Blanco MJ; Marquez M; Soto MJ; Fernandez-Gutiérrez C; Rodriguez-Ramos C; Giron-Gonzalez JA
Liver Int; 2011 Jul; 31(6):850-8. PubMed ID: 21645216
[TBL] [Abstract][Full Text] [Related]
3. Bacterial translocation and nonselective β-blockers in portal hypertension: where we are, what we still need.
La Mura V; Colombo M
Gastroenterology; 2014 Jul; 147(1):247-9. PubMed ID: 24866430
[No Abstract] [Full Text] [Related]
4. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
5. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
Albillos A; de la Hera A; González M; Moya JL; Calleja JL; Monserrat J; Ruiz-del-Arbol L; Alvarez-Mon M
Hepatology; 2003 Jan; 37(1):208-17. PubMed ID: 12500206
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
[TBL] [Abstract][Full Text] [Related]
7. Commentary: non-haemodynamic effects of beta-blockers in cirrhosis--more than meets the eye?
Sharma S; Feld JJ
Aliment Pharmacol Ther; 2013 Sep; 38(6):652. PubMed ID: 23964732
[No Abstract] [Full Text] [Related]
8. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
[TBL] [Abstract][Full Text] [Related]
9. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
[TBL] [Abstract][Full Text] [Related]
10. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
[TBL] [Abstract][Full Text] [Related]
11. Commentary: non-haemodynamic effects of beta-blockers in cirrhosis - more than meets the eye? Authors' reply.
Bajaj JS; Ratliff S; Lapane K
Aliment Pharmacol Ther; 2013 Sep; 38(6):653. PubMed ID: 23964733
[No Abstract] [Full Text] [Related]
12. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
[TBL] [Abstract][Full Text] [Related]
13. Dual-sugar tests of small intestinal permeability are poor predictors of bacterial infections and mortality in cirrhosis: A prospective study.
Vogt A; Reuken PA; Stengel S; Stallmach A; Bruns T
World J Gastroenterol; 2016 Mar; 22(11):3275-84. PubMed ID: 27004006
[TBL] [Abstract][Full Text] [Related]
14. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality.
de Oca Arjona MM; Marquez M; Soto MJ; Rodriguez-Ramos C; Terron A; Vergara A; Arizcorreta A; Fernandez-Gutierrez C; Giron-González JA
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):420-7. PubMed ID: 21266909
[TBL] [Abstract][Full Text] [Related]
15. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum.
Melichar B; Hyspler R; Dragounová E; Dvorák J; Kalábová H; Tichá A
BMC Cancer; 2007 Aug; 7():155. PubMed ID: 17688683
[TBL] [Abstract][Full Text] [Related]
17. Assessment of response to beta-blockers by expression of βArr2 and RhoA/ROCK2 in antrum mucosa in cirrhotic patients.
Trebicka J; von Heydebrand M; Lehmann J; Tofteng F; Busk T; Jensen HL; Rohde J; Reiberger T; Mortensen C; Schierwagen R; Klein S; Møller S; Bendtsen F; Krag A
J Hepatol; 2016 Jun; 64(6):1265-73. PubMed ID: 26827791
[TBL] [Abstract][Full Text] [Related]
18. Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites.
Rincón D; Vaquero J; Hernando A; Galindo E; Ripoll C; Puerto M; Salcedo M; Francés R; Matilla A; Catalina MV; Clemente G; Such J; Bañares R
Liver Int; 2014 Nov; 34(10):1504-12. PubMed ID: 24661740
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
20. Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.
Wang D; Wang Q; Yin J; Dong R; Wang Q; Du X; Lu J
J Gastroenterol Hepatol; 2016 May; 31(5):1037-44. PubMed ID: 26487394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
